Two graphs compare cumulative CIN2+ probability (%) over 10 years. Graph A shows discrete groups: HPV-negative/normal cytology, HPV-negative/abnormal cytology, HPV-positive/normal cytology, and HPV-positive/abnormal cytology. Graph B shows overlapping groups: Normal cytology, HPV-negative, and Normal cytology/HPV-negative.

After a negative #HPV test, long-term risk of cervical precancer remained low, indicating limited additional benefit of adding cytology (#Cotesting) compared with primary HPV screening for cervical cancer.

ja.ma/4bjDP1z